Psilocybin
赛洛西宾
Report date: 2026/05/23 20:00:57
Base Information
Drug NamePsilocybin
Drug Alias Name +[7]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[83]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[19]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesTRYP Therapeutics Inc
China Registration ClassN/A
Develop Information
Active CompaniesDell Medical School At The University Of Texas At AustinUtah State UniversityDana-Farber Cancer Institute +[74]
Inactive CompaniesUniversity Of MinnesotaUniversity Of HelsinkiNational Cancer Institute +[7]
Active Indications +[73]
Inactive Indications +[10]